Press Releases

CANCER Announces New Editor-In-Chief
Apr 21, 2021

CANCER, a peer-reviewed journal of the American Cancer Society, today announced that Suresh S. Ramalingam, MD, will join the journal as the new editor-in-chief, with a 5-year editorship beginning on July 1, 2021. Dr. Ramalingam is internationally recognized for his research, specifically for the development of individualized therapies for patients with small cell and non-small cell lung cancer. 

Currently, Dr. Ramalingam is deputy director of Winship Cancer Institute of Emory University, where he leads the integration of the research, clinical, and educational components, and is assistant dean for cancer research at Emory University School of Medicine. He has worked with CANCER as the editor for the journal’s Chest and Lung Disease, Clinical Trials, and Medical Oncology sections since 2011. 

“I am incredibly honored to serve as the new editor-in-chief of CANCER, one of the oldest and most prestigious oncology journals, which has been positioned as an important global forum for exchange of scientific knowledge under the leadership of my predecessor Dr. Fadlo R. Khuri,” said Dr. Ramalingam. “I look forward to continuing to position CANCER as a destination journal of major research discoveries and to help the journal grow in reputation and impact.” 

Dr. Ramalingam succeeds Dr. Khuri, who leaves the editor-in-chief position after 10 years of providing vision, leadership, and dedicated service to help increase the journal’s visibility among some of the top research journals in the field. During his tenure, submissions to CANCER increased by over 40% and full-text accesses to the journal’s online content more than doubled, making it the most downloaded medical journal on Wiley Online Library. 

“We are incredibly grateful for all that Dr. Khuri has done to elevate CANCER’s esteemed format and reputation within the oncology community as he is praised by his colleagues for his dedication to the journal,” said William G. Cance, MD, Chief Medical and Scientific Officer, American Cancer Society. “We are excited to continue that legacy and scientific impact of the journal among leading researchers under the new editorship of Dr. Ramalingam.” 

Dr. Ramalingam holds additional titles at Emory University School of Medicine including professor of hematology and medical oncology, director of the Division of Medical Oncology, and the Roberto C. Goizueta Distinguished Chair for Cancer Research. 

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.